TRZAX Performance — T. Rowe Price Value Fund, Inc., Z Class
Data updated: 2026-08-27
TRZAX returned +15.08% year to date and +21.78% over one year to Jun 2026. Annualised returns are +17.58% over 3 years and +10.70% over 5 years. The fund beat its US Large Value category average: $100 invested three years ago grew to $163, against $158 for the category, and to $122 over one year, against $121. Volatility over the past three years was 12.25% a year. In the 12 months to Jun 2026 the fund lost a net $694.0M, and assets reached $33.99B.
TRZAX Growth of $100
What $100 invested in T. Rowe Price Value Fund, Inc. grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | TRZAX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $122 | $121 |
| 3 years (Jul 2023 – Jun 2026) | $163 | $158 |
| 5 years (Jul 2021 – Jun 2026) | $166 | $165 |
| Since data start (Mar 2020 – Jun 2026) | $326 | $229 |
TRZAX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +15.08% |
| 1 year | +21.78% |
| 3 years (annualised) | +17.58% |
| 5 years (annualised) | +10.70% |
TRZAX Annual Returns
Calendar-year total returns of T. Rowe Price Value Fund, Inc., compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +15.08% |
| 2025 | +12.95% |
| 2024 | +15.85% |
| 2023 | +12.92% |
| 2022 | −10.75% |
| 2021 | +30.88% |
| 2020 (Mar–Dec) | +64.09% |
TRZAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.2% | +4.9% | −5.4% | +7.3% | +0.1% | +2.5% | — | — | — | — | — | — |
| 2025 | +5.2% | +1.2% | −1.1% | −3.5% | +2.6% | +2.4% | −0.2% | +3.2% | +0.8% | −1.1% | +2.9% | +0.1% |
| 2024 | +1.4% | +4.9% | +5.3% | −2.7% | +3.0% | −1.1% | +3.5% | +3.1% | +0.3% | −1.2% | +6.1% | −7.0% |
| 2023 | +2.9% | −2.9% | −0.2% | +2.4% | −3.2% | +5.9% | +3.6% | −2.4% | −2.9% | −2.5% | +7.4% | +4.9% |
| 2022 | −4.6% | −1.1% | +3.3% | −6.4% | +0.7% | −6.8% | +4.9% | −2.7% | −8.1% | +9.3% | +5.0% | −3.1% |
| 2021 | +0.3% | +6.7% | +5.0% | +5.1% | +2.4% | −1.1% | +2.0% | +3.5% | −4.6% | +6.9% | −3.8% | +5.8% |
| 2020 | — | — | +10.4% | +9.7% | +4.3% | +1.1% | +5.6% | +4.9% | −2.4% | +1.4% | +12.9% | +3.9% |
TRZAX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 12.25%
- 3-year Sharpe ratio: 1.07 (vs 4.5% risk-free rate)
- Best month: +7.44% (Nov 2023)
- Worst month: −7.04% (Dec 2024)
TRZAX Fund Flows
Monthly money in and out of T. Rowe Price Value Fund, Inc., from SEC Form N-PORT.
- 12-month net flow: −$694.0M
- 12-month gross sales (incl. reinvestments): $6.0B
- Sales ÷ redemptions: 0.90×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $1.7B | $2.2B | −$423.2M |
| May 2026 | $328.8M | $596.9M | −$268.1M |
| Apr 2026 | $114.0M | $497.7M | −$383.7M |
| Mar 2026 | $172.7M | $317.5M | −$144.8M |
| Feb 2026 | $273.8M | $343.3M | −$69.5M |
| Jan 2026 | $398.9M | $568.9M | −$170.0M |
| Dec 2025 | $1.8B | $424.2M | $1.4B |
| Nov 2025 | $644.7M | $300.3M | $344.4M |
| Oct 2025 | $164.2M | $398.3M | −$234.1M |
| Sep 2025 | $150.1M | $433.8M | −$283.7M |
| Aug 2025 | $105.0M | $266.7M | −$161.7M |
| Jul 2025 | $159.7M | $419.4M | −$259.7M |
TRZAX Assets Under Management
Net assets of T. Rowe Price Value Fund, Inc. by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $33.99B |
| 2026-03-31 | $31.88B |
| 2025-12-31 | $30.89B |
| 2025-09-30 | $30.35B |
| 2025-06-30 | $29.93B |
| 2025-03-31 | $30.32B |
| 2024-12-31 | $29.20B |
| 2024-09-30 | $31.19B |
| 2024-06-30 | $29.39B |
| 2024-03-31 | $30.28B |
| 2023-12-31 | $27.61B |
| 2023-09-30 | $25.74B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.